Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

Blood (2023) 141 (3): 244–259.

https://doi.org/10.1182/blood.2022016580

Published: 2023

Includes: Supplemental data

Journal Articles

Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients

Muhammad Umair Mushtaq, Joe S Al-Ramahi, Kevin S Li, Moazzam Shahzad, Sibgha Gull Chaudhary, Ramesh Balusu, Nausheen Ahmed, Rajat Bansal, Haitham Abdelhakim, Leyla O. Shune, Anurag K. Singh, Sunil H Abhyankar, Joseph P. McGuirk

Blood (2022) 140 (Supplement 1): 10481–10483.

https://doi.org/10.1182/blood-2022-158716

Published: 2022

Journal Articles

Proxe: A Public Repository of Xenografts to Facilitate Studies of Biology and Expedite Preclinical Drug Development in Leukemia and Lymphoma

Mark A. Murakami, MD MA, Alexandra N. Christodoulou, M.S., Amanda L Christie, B.S., Tiffany DeSouza, B.S., Abner Louissaint, Jr., MD PhD, Una Vojinovic, B.S., Raphael Koch, MD, Loretta S. Li, MD, Scott P. Kallgren, PhD, Prakash Rao, PhD, Johannes Köster, PhD, Raga Vadhi, M.S., Eilene Duberow, B.S., Elizabeth A. Morgan, MD, Hongjun Wang, Samia S. Ahmed, Katharine L. Majewski, Marina Konopleva, MD PhD, Jerome Tamburini, MD, PhD, Alejandro Gutierrez, MD, Michelle Kelliher, PhD, Julia Etchin, PhD, Irmela Jeremias, MD, Andrew P. Weng, MD PhD, Andrew L Kung, MD PhD, Andrew A Lane, MD PhD, Francine Garnache-Ottou, PhD, Shai Izraeli, MD Prof, Eric Jacobsen, MD, Ilene Galinsky, ANP, Richard M. Stone, MD, Marian H. Harris, MD PhD, David M. Dorfman, MD PhD, Jon C Aster, MDPhD, Henry Long, PhD, Lewis B. Silverman, MD, David M Weinstock, MD

Blood (2015) 126 (23): 3252.

https://doi.org/10.1182/blood.V126.23.3252.3252

Published: 2015

Journal Articles

B and T-Cell Lymphoma Patient-Derived Xenografts Recapitulate Aspects of Disease Biology and Progression and Represent Novel Tools for Preclinical Drug Development

Blood (2015) 126 (23): 4001.

https://doi.org/10.1182/blood.V126.23.4001.4001

Published: 2015

Journal Articles

Lower Dose Lenalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma Who Are Aged 60 Years or over and/or at Risk of Myelosuppression: Final Analysis of the Revlite Trial and Matched Comparison to the MM009 and MM010 Trials

Hang Quach, MD, Simon Harrison, MD, Liam J. Fernyhough, MB, BS, BMedSci, Ross Alistair Henderson, PhD FRACP, FRCPA, Gillian Corbett, MDFRACP FRCPA, Peter Browett, MBChB, FRACP, FRCPA, Hilary Anne Blacklock, FRACP, Craig Underhill, MD, Paul Cannell, MD, Judith Trotman, MBChB, Emma Link, Linda Cowan, Jack S Li, Meletios A. Dimopoulos, H. Miles Prince, MD

Blood (2015) 126 (23): 4236.

https://doi.org/10.1182/blood.V126.23.4236.4236

Published: 2015

Journal Articles

Type II JAK2 Inhibitor NVP-CHZ868 Is Active in Vivo Against JAK2-Dependent B-Cell Acute Lymphoblastic Leukemias (B-ALLs)

Blood (2014) 124 (21): 3713.

https://doi.org/10.1182/blood.V124.21.3713.3713

Published: 2014

Journal Articles

The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development

Haiyan S. Li, Cliff Y. Yang, Kalyan C. Nallaparaju, Huiyuan Zhang, Yong-Jun Liu, Ananda W. Goldrath, Stephanie S. Watowich

Blood (2012) 120 (22): 4363–4373.

https://doi.org/10.1182/blood-2012-07-441311

Published: 2012

Includes: Supplemental data

Journal Articles

Cell-intrinsic role for IFN-α–STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response

Haiyan S. Li, Alexander Gelbard, Gustavo J. Martinez, Eiji Esashi, Huiyuan Zhang, Hoainam Nguyen-Jackson, Yong-Jun Liu, Willem W. Overwijk, Stephanie S. Watowich

Blood (2011) 118 (14): 3879–3889.

https://doi.org/10.1182/blood-2011-04-349761

Published: 2011

Includes: Supplemental data

Journal Articles

Intersecting Chemical Genomic and Genetic Screens Identifies Glycogen Synthase Kinase-3α (GSK-3α) as a Modulator of Differentiation In Acute Myeloid Leukemia

Versha Banerji, MD, Kenneth N. Ross, PhD, Loretta S. Li, MD, Stacey M. Frumm, Anna C. Schinzel, PhD, Cynthia K. Hahn, Rose M. Kakoza, MD, Kwan T. Chow, Linda Ross, PhD, Haig Inguilizian, MD, Ilene Galinsky, ANP, Richard M Stone, MD, Daniel J DeAngelo, MD, PhD, William C. Hahn, MD, PhD, Andrew L. Kung, MD, PhD, Kimberly Stegmaier, MD

Blood (2010) 116 (21): 1000.

https://doi.org/10.1182/blood.V116.21.1000.1000

Published: 2010

Journal Articles

STAT3 controls myeloid progenitor growth during emergency granulopoiesis

Huiyuan Zhang, Hoainam Nguyen-Jackson, Athanasia D. Panopoulos, Haiyan S. Li, Peter J. Murray, Stephanie S. Watowich

Blood (2010) 116 (14): 2462–2471.

https://doi.org/10.1182/blood-2009-12-259630

Published: 2010

Journal Articles

STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF–induced CXCR2 expression and via modulation of CXCR2 signal transduction

Hoainam Nguyen-Jackson, Athanasia D. Panopoulos, Huiyuan Zhang, Haiyan S. Li, Stephanie S. Watowich

Blood (2010) 115 (16): 3354–3363.

https://doi.org/10.1182/blood-2009-08-240317

Published: 2010

Journal Articles

STAT3 Controls the Neutrophil Migratory Response to CXCR2 Ligands by Direct Activation of G-CSF-Responsive CXCR2 Expression and Via Modulation of CXCR2 Signal Transduction .

Hoainam Nguyen-Jackson, Athanasia Panopoulos, Huiyuan Zhang, Haiyan S. Li, Stephanie Watowich, PhD

Blood (2009) 114 (22): 236.

https://doi.org/10.1182/blood.V114.22.236.236

Published: 2009

Journal Articles

STAT3 Controls Neutrophil Progenitor Growth and Differentiation During Emergency Granulopoiesis.

Huiyuan Zhang, Hoainam Nguyen-Jackson, Athanasia Panopoulos, Haiyan S Li, Peter J Murray, Stephanie Watowich, PhD

Blood (2009) 114 (22): 3619.

https://doi.org/10.1182/blood.V114.22.3619.3619

Published: 2009

Journal Articles

Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? .

Loretta S. Li, BS, Dezheng Huo, MS, Theodore Karrison, PhD, Richard A. Larson, MD, Olufunmilayo Olopade, MD

Blood (2004) 104 (11): 2018.

https://doi.org/10.1182/blood.V104.11.2018.2018

Published: 2004

Journal Articles

A Novel Triple Purge Strategy for Eliminating Chronic Myelogenous Leukemia (CML) Cells from Autografts.

H. Yang, C. Eaves, M. de Lima, M. Lee, R. Champlin, J. McMannis, S. Robinson, T. Niu, W. Decker, D. Xing, M. Thomas, J. Ng, S. Li, A. Eaves, R. Jones, B. Andersson, E. Shpall

Blood (2004) 104 (11): 152.

https://doi.org/10.1182/blood.V104.11.152.152

Published: 2004

Journal Articles

The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties

SP Hunger, S Li, MZ Fall, L Naumovski, ML Cleary

Blood (1996) 87 (11): 4607–4617.

https://doi.org/10.1182/blood.V87.11.4607.bloodjournal87114607

Published: 1996

NARROW

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients

Proxe: A Public Repository of Xenografts to Facilitate Studies of Biology and Expedite Preclinical Drug Development in Leukemia and Lymphoma

B and T-Cell Lymphoma Patient-Derived Xenografts Recapitulate Aspects of Disease Biology and Progression and Represent Novel Tools for Preclinical Drug Development

Lower Dose Lenalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma Who Are Aged 60 Years or over and/or at Risk of Myelosuppression: Final Analysis of the Revlite Trial and Matched Comparison to the MM009 and MM010 Trials

Type II JAK2 Inhibitor NVP-CHZ868 Is Active in Vivo Against JAK2-Dependent B-Cell Acute Lymphoblastic Leukemias (B-ALLs)

The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development

Cell-intrinsic role for IFN-α–STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response

Intersecting Chemical Genomic and Genetic Screens Identifies Glycogen Synthase Kinase-3α (GSK-3α) as a Modulator of Differentiation In Acute Myeloid Leukemia

STAT3 controls myeloid progenitor growth during emergency granulopoiesis

STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF–induced CXCR2 expression and via modulation of CXCR2 signal transduction

STAT3 Controls the Neutrophil Migratory Response to CXCR2 Ligands by Direct Activation of G-CSF-Responsive CXCR2 Expression and Via Modulation of CXCR2 Signal Transduction .

STAT3 Controls Neutrophil Progenitor Growth and Differentiation During Emergency Granulopoiesis.

Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? .

A Novel Triple Purge Strategy for Eliminating Chronic Myelogenous Leukemia (CML) Cells from Autografts.

The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only